Rainbow Childrens Medicare Ltd

Rainbow Childrens Medicare Ltd

₹ 1,355 0.76%
22 May - close price
About

Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care, obstetrics, and gynecology. [1] It is country’s largest pediatric hospital chain with 16 hospitals spread across 6 cities.[2]

Key Points

Business Overview[1]
The company operates 22 hospitals and 5 clinics across 9 cities, with a total bed capacity of 2,285. It specializes in pediatric healthcare under "Rainbow Children's Hospital" and women's healthcare under "Birthright by Rainbow."

  • Market Cap 13,761 Cr.
  • Current Price 1,355
  • High / Low 1,646 / 1,009
  • Stock P/E 49.2
  • Book Value 162
  • Dividend Yield 0.22 %
  • ROCE 18.2 %
  • ROE 17.9 %
  • Face Value 10.0

Pros

  • Company's median sales growth is 22.8% of last 10 years

Cons

  • Stock is trading at 8.35 times its book value
  • Working capital days have increased from 52.8 days to 95.4 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
317 287 333 336 341 330 417 398 370 353 445 445 460
219 199 215 218 236 236 270 264 255 249 296 298 315
Operating Profit 98 88 118 118 106 94 147 134 115 104 149 147 145
OPM % 31% 31% 35% 35% 31% 28% 35% 34% 31% 29% 33% 33% 31%
9 8 8 9 13 12 11 13 15 20 8 11 4
Interest 14 15 13 14 17 18 18 18 18 18 19 20 20
Depreciation 23 25 27 28 32 34 35 35 34 34 36 40 41
Profit before tax 70 56 85 85 69 53 105 94 77 71 102 98 87
Tax % 23% 25% 26% 26% 26% 26% 25% 27% 27% 25% 26% 24% 10%
54 42 63 63 51 40 79 69 57 54 76 74 78
EPS in Rs 5.28 4.04 6.20 6.12 5.02 3.89 7.77 6.76 5.55 5.27 7.41 7.14 7.59
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
169 234 321 402 543 719 650 974 1,174 1,297 1,516 1,703
128 204 266 332 391 519 485 666 774 865 1,022 1,159
Operating Profit 41 30 55 69 151 201 165 308 400 432 494 544
OPM % 24% 13% 17% 17% 28% 28% 25% 32% 34% 33% 33% 32%
10 16 11 10 8 10 10 19 31 37 51 42
Interest 3 3 3 4 42 48 46 56 58 63 77 78
Depreciation 9 18 22 28 60 69 73 83 90 112 138 151
Profit before tax 38 24 41 47 58 93 56 187 282 295 330 358
Tax % 35% 28% 24% 22% 22% 41% 29% 26% 25% 26% 26% 21%
25 17 31 36 45 55 40 139 212 218 244 282
EPS in Rs 26.74 18.22 33.78 8.25 10.14 12.68 9.10 14.70 20.77 21.38 23.97 27.40
Dividend Payout % 7% 11% 7% 12% 10% 16% 0% 14% 14% 14% 13% 13%
Compounded Sales Growth
10 Years: 22%
5 Years: 21%
3 Years: 13%
TTM: 12%
Compounded Profit Growth
10 Years: 32%
5 Years: 48%
3 Years: 10%
TTM: 18%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 12%
1 Year: 0%
Return on Equity
10 Years: 18%
5 Years: 20%
3 Years: 18%
Last Year: 18%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 9 9 9 44 44 44 44 94 102 102 102 102
Reserves 166 275 308 307 317 350 391 498 958 1,157 1,367 1,547
22 24 26 24 476 501 529 592 570 765 764 891
34 41 55 73 89 123 116 112 146 146 145 236
Total Liabilities 231 349 399 448 926 1,019 1,081 1,296 1,776 2,170 2,377 2,775
78 123 174 296 702 702 772 858 931 1,253 1,398 1,759
CWIP 35 31 7 12 23 43 29 6 23 20 28 76
Investments 7 2 6 0 3 10 18 22 58 308 571 404
111 194 212 140 199 265 262 409 764 590 380 535
Total Assets 231 349 399 448 926 1,019 1,081 1,296 1,776 2,170 2,377 2,775

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
26 17 36 48 127 170 143 224 327 321 396 420
-20 -107 -33 -42 -117 -117 -83 -175 -465 -226 -268 -259
-7 93 -1 -7 -9 -52 -61 -44 143 -102 -118 -147
Net Cash Flow -1 3 1 -2 2 2 -1 4 5 -7 10 14
Free Cash Flow -35 -46 -21 -103 42 96 67 162 186 -32 250 204
CFO/OP 95% 88% 79% 88% 94% 95% 102% 93% 102% 95% 97% 96%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 11 10 16 14 24 22 25 15 18 20 19 22
Inventory Days 39 35 48 36 32 55 36 28 43 53 52 67
Days Payable 121 107 142 151 197 202 190 121 195 180 170 162
Cash Conversion Cycle -72 -62 -79 -100 -141 -124 -130 -78 -133 -107 -100 -73
Working Capital Days -35 -36 -28 -31 -26 -18 -17 -16 73 44 19 95
ROCE % 22% 11% 14% 14% 16% 16% 11% 23% 24% 19% 19% 18%

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Dec 2025
Bed Capacity (Total)
Number

Log in to view insights

Please log in to see hidden values.

Login
ALOS (Average Length of Stay)
Days
ARPOB (Average Revenue Per Occupied Bed)
INR/Day
Inpatient Discharges
Number
Number of Deliveries
Number
Occupancy
Percentage
Operational Beds
Number
Outpatient Consultations
Number

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
49.83% 49.83% 49.83% 49.83% 49.87% 49.85% 49.85% 49.85% 49.85% 49.85% 49.84% 49.84%
20.20% 21.63% 22.32% 24.04% 24.78% 25.12% 25.12% 23.69% 23.60% 21.85% 19.24% 17.24%
15.36% 15.39% 15.62% 14.76% 13.81% 13.84% 13.87% 15.31% 15.44% 17.46% 19.49% 21.12%
14.63% 13.14% 12.23% 11.37% 11.53% 11.20% 11.16% 11.14% 11.11% 10.82% 11.40% 11.68%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.04% 0.12%
No. of Shareholders 74,69079,18780,47177,15278,55777,52478,76479,09280,32081,13488,80988,561

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls